California Resources Corporation enters the back half of May with a fresh upgrade on the tape and a meaningful unwind of bearish positioning — two signals pointing in the same direction on a name that endured some sharp post-earnings pain earlier this month.
The clearest development this week is on the Street. Citigroup's Scott Gruber moved CRC to Buy from Neutral this morning, lifting his target to $78 from $74 — making this the most significant rating change in months for a stock that had been sitting in neutral with Citi since late March. With eight buy ratings and zero holds among tracked analysts, the consensus is uniformly constructive. The mean price target of $81.27 implies roughly 30% upside to the current $62.47 close. UBS trimmed its target earlier in the month to $78 from $82 while keeping its Buy — a sign of modest recalibration after earnings rather than a shift in conviction. Wells Fargo and Barclays both carry Overweight ratings from March, with targets in the $72-$76 range. The Street is aligned; the debate is entirely about the pace of recovery.
Positioning has shifted notably since the early-May earnings sell-off. Short interest in CRC has fallen 8.2% on the week and 13.8% over the past month, pulling the float short from roughly 4.5% following the May results to 3.5% now. That's a material reduction in just a few weeks — shorts who pushed in around the earnings release are covering into the rally. Availability in the borrow market is extremely loose at over 2,200%, well above even the 52-week maximum tightness of around 441%, meaning the lending pool is far from stressed. Cost to borrow is minimal at 0.48%, up modestly on the week but not a meaningful signal. There is no squeeze dynamic here — shorts are leaving because they choose to, not because they're being forced out.
Options positioning has ticked more defensive this week, but not by an alarming margin. The put/call ratio is running at 0.67, slightly above its 20-day average of 0.60 and about 1.2 standard deviations above the norm. That's a gentle lean toward protection rather than a strong hedging signal — the 52-week high on the PCR is 1.22, so the current reading is far from stretched. The modest caution is consistent with a stock that fell over 12% the day after Q1 results were released on May 6, with a five-day post-earnings move of more than 15% to the downside. The May report also triggered an almost identical reaction the prior session, confirming the market came in expecting more and sold the numbers hard.
The stock has clawed back nearly 5% on the week to $62.47, recovering a portion of the post-earnings drop. Peers have broadly moved with it: PR gained 5.2% on the week, MTDR added 8.9%, and CRGY rose 7.9% — suggesting energy sector tailwinds are lifting the whole group, with CRC broadly keeping pace. The short score has eased from a recent high of 40.2 on May 8 down to 36.0, consistent with the short-covering trend. EPS momentum over 90 days ranks in the 94th percentile — one of the stronger readings in the sector — which provides the fundamental underpinning for the bullish analyst stance, even as the 30-day momentum score has retreated to just the 19th percentile following the earnings-driven reset.
The next scheduled earnings release is August 3. Between now and then, the key watch-points are whether shorts continue to exit as the stock rebuilds from the post-earnings low, and whether the Citi upgrade draws in fresh institutional interest to complement what has already been a notably concentrated holder base — BlackRock, Vanguard, and Canada Pension together hold over 30% of shares outstanding.
See the live data behind this article on ORTEX.
Open CRC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
